Dalmevin 50 mg tablete

Name	Dalmevin 50 mg tablete
Marketing Authorisation Number	HR-H-215024398
Active Substance	vildagliptin
Composition	svaka tableta sadrži 50 mg vildagliptina
Pharmaceutical Form	tableta
Manufacturer	Medochemie Ltd., Limassol, Cipar
Marketing Authorisation Holder	Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar
Marketing Authorisation Date	07.01.2022
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/21-02/140
Registration Number	381-12-01/38-22-04
Prescription	Medicinal product subject to medical prescription
Type of prescription	ponovljivi recept
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	A10BH02
Marketing status	stavljeno u promet
Shortage status	nema nestašice
SmPC	download
PL	download
Public Assessment Report	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
7 tableta u blisteru, u kutiji	HR-H-215024398-01	-	-
14 tableta u blisteru, u kutiji	HR-H-215024398-02	-	-
28 tableta u blisteru, u kutiji	HR-H-215024398-03	-	-
30 tableta u blisteru, u kutiji	HR-H-215024398-04	-	-
56 tableta u blisteru, u kutiji	HR-H-215024398-05	nije stavljeno u promet	-
60 tableta u blisteru, u kutiji	HR-H-215024398-06	stavljeno u promet	nema nestašice
90 tableta u blisteru, u kutiji	HR-H-215024398-07	-	-
112 tableta u blisteru, u kutiji	HR-H-215024398-08	-	-
180 tableta u blisteru, u kutiji	HR-H-215024398-09	-	-
336 tableta u blisteru, u kutiji	HR-H-215024398-10	-	-

Medicinal Products